FULGENT GENETICS
Fulgent Genetics is a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health. Fulgent’s proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy, and competitive turnaround times. Combining next generation sequencing (“NGS”) with its technology ... platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs. A cornerstone of the Company’s business is its ability to provide expansive options and flexibility for all clients’ unique testing needs through a comprehensive technology offering including cloud computing, pipeline services, record management, web portal services, clinical workflow, sequencing as a service, and automated lab services.
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Fuse Oncology
Fuse Oncology creates a software solutions for healthcare specially oncology.
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2022-04-18 | Inform Diagnostics | Inform Diagnostics acquired by Fulgent Genetics | N/A |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-07-15 | Helio Health | Fulgent Genetics investment in Series B - Helio Health | 118 M USD |
More informations about "Fulgent Genetics"
About Us - Fulgent Genetics
Fulgent Genetics was the first clinical laboratory to offer copy number variation detection using NGS technology in the United States. Today, we continue to offer an unrivaled catalog of …See details»
Familial Known Mutation Test | Fulgent Genetics
Please indicate the genetic variant (gene name and variant description) for which the known mutation testing is requested, as well as the original proband's name, relationship to the …See details»
News Release - Fulgent Genetics
Fulgent Genetics Announces Incremental Strategic Investment in Chinese Joint Venture, FF Gene Biotech ... China and expand the sales organization supporting Fulgent’s growth initiatives. …See details»
Whole Genome NGS Panel | Fulgent Genetics
The American College of Medical Genetics and Genomics (ACMG) recommends genome or exome as a first-line test for developmental delay, intellectual disability, and congenital …See details»
Foundation Medicine & Fulgent Genetics Launch Germline Testing
Feb 7, 2025 Meanwhile, Fulgent Genetics is a technology-driven organization involved in various genomic diagnostics and precision medicine facilities, laboratory services, and developing …See details»
Fulgent BioPharma
QPCR allows for the amplification and analysis of genetic material from a variety of sample types, including cells and tissues. Fulgent BioPharma offers custom and commercial assays.See details»
Fulgent Genetics - ClinGen | Clinical Genome Resource
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health …See details»
Genomic Tests | Fulgent Genetics
Fulgent is an accredited leader in clinical diagnostic genetic sequencing. Test Count: 6 Genomic Tests. C. ... Fulgent Genetics 4399 Santa Anita Ave El Monte, CA 91731 Contact Phone: +1 …See details»
Fulgent Genetics, Inc. - Drug pipelines, Patents, Clinical trials
Jan 23, 2025 EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory …See details»
Single Genes | Fulgent Genetics
Fulgent is an accredited leader in clinical diagnostic genetic sequencing.See details»
Fulgent Australia | Genetic Testing
At Fulgent Australia, we make a difference by delivering clinically relevant results with speed, precision, and dedication. We know every patient is unique. The breadth and granularity of our …See details»
Segregation Testing - Fulgent Genetics
Occasionally, individuals may receive a genetic testing report with an uncertain result, called a "variant of uncertain significance" ("VUS"). When this occurs, it can be useful to test additional …See details»
Foundation Medicine to Launch Hereditary Germline Tests, …
Feb 4, 2025 These tests will be offered through a partnership with Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”). The companies are planning for healthcare providers to be able …See details»
Fulgent Genetics Welcomes Dr. Michael Nohaile and Dr. Leonard …
Aug 1, 2022 Fulgent Genetics is a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health. …See details»
Genomic Testing - Fulgent Genetics
Fulgent's rwgs Panel Coverage: Focus on genes related to clinical notes + pre-set NICU gene list Gene Details: >96% of the genome @ 20x; typical average coverage @ 30-45xSee details»
Genomic Testing | Fulgent Genetics
Mar 5, 2022 An RNA-integrated approach is expected to increase the overall diagnostic rate up to 52% through the detection of abnormal gene expression, aberrant splicing, or mono-allelic …See details»
How It Works - Fulgent Genetics
Consultations with genetic counselors are available to providers for an explanation of results or to assist in ordering questions. Additional Testing If a result is inconclusive, we offer a number of …See details»
The Relationship Between Fulgent and Picture, Explained - Picture …
What’s Fulgent Genetics got to do with Picture Genetics? They’re the same company, and the same laboratory, but they each provide different services. The Relationship Between Fulgent …See details»
Beacon Preconception Expanded Carrier Screening (With X-linked ...
This panel may be used to provide reproductive pairs with a thorough evaluation of their risk to have a child with a genetic condition. Beacon Preconception carrier screening panels are …See details»
Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug ...
Mar 20, 2025 Fulgent Genetics' Price to Book Ratio is ranked better in valuation than 88% of 206 companies in the research & diagnostics industry. The industry median is 2.16 and the …See details»